GSEA analysis indicated a positive correlation between IGF2BP3 levels and “INFLAMMATORY RESPONSE” and “ALLOGRAFT REJECTION” in bladder cancer datasets (Fig. 7A–C). The gene discussed is IGF2BP3; the disease is urinary bladder carcinoma.